Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hongbin Ji

Showing results (201-210 of 214) with videos related to

Pageof 22
Sort By:
Cell|January 5, 2024
Proteogenomic characterization of small cell lung cancer identifies biological insights and subtype-specific therapeutic strategiesQian Liu, Jing Zhang, Chenchen Guo, et al.
Cancer Cell|May 6, 2014
Loss of Lkb1 and Pten leads to lung squamous cell carcinoma with elevated PD-L1 expressionChunxiao Xu, Christine M Fillmore, Shohei Koyama, et al.
The Journal of Experimental Medicine|January 29, 2024
EML4-ALK fusions drive lung adeno-to-squamous transition through JAK-STAT activationZhen Qin, Meiting Yue, Shijie Tang, et al.
Biorxiv : the Preprint Server for Biology|May 3, 2023
<i>In vivo</i> metabolomics identifies CD38 as an emergent vulnerability in <i>LKB1</i> -mutant lung cancerJiehui Deng, David H Peng, David Fenyo, et al.
Cancer Cell|June 15, 2010
Integrative genomic and proteomic analyses identify targets for Lkb1-deficient metastatic lung tumorsJulian Carretero, Takeshi Shimamura, Klarisa Rikova, et al.
Cancer Cell|December 16, 2022
KMT2D deficiency drives lung squamous cell carcinoma and hypersensitivity to RTK-RAS inhibitionYuanwang Pan, Han Han, Hai Hu, et al.
Cancer Immunology Research|August 31, 2021
Targeting the Atf7ip-Setdb1 Complex Augments Antitumor Immunity by Boosting Tumor ImmunogenicityHai Hu, Alireza Khodadadi-Jamayran, Igor Dolgalev, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2016
Heterogeneous Mechanisms of Primary and Acquired Resistance to Third-Generation EGFR InhibitorsSandra Ortiz-Cuaran, Matthias Scheffler, Dennis Plenker, et al.
Nature Communications|April 8, 2017
Lkb1 inactivation drives lung cancer lineage switching governed by Polycomb Repressive Complex 2Haikuo Zhang, Christine Fillmore Brainson, Shohei Koyama, et al.
Journal of Respiratory Biology and Translational Medicine|December 23, 2024
Progress and Gaps in Respiratory Disease Research and Treatment: Highlights of the IRM 2024 in ShanghaiJin-San Zhang, Qhaweni Dhlamini, Qiang Guo, et al.
Pageof 22

Showing results (201-210 of 214) with videos related to

Sort By:
Pageof 22
Cell|January 5, 2024
Proteogenomic characterization of small cell lung cancer identifies biological insights and subtype-specific therapeutic strategiesQian Liu, Jing Zhang, Chenchen Guo, et al.
Cancer Cell|May 6, 2014
Loss of Lkb1 and Pten leads to lung squamous cell carcinoma with elevated PD-L1 expressionChunxiao Xu, Christine M Fillmore, Shohei Koyama, et al.
The Journal of Experimental Medicine|January 29, 2024
EML4-ALK fusions drive lung adeno-to-squamous transition through JAK-STAT activationZhen Qin, Meiting Yue, Shijie Tang, et al.
Biorxiv : the Preprint Server for Biology|May 3, 2023
<i>In vivo</i> metabolomics identifies CD38 as an emergent vulnerability in <i>LKB1</i> -mutant lung cancerJiehui Deng, David H Peng, David Fenyo, et al.
Cancer Cell|June 15, 2010
Integrative genomic and proteomic analyses identify targets for Lkb1-deficient metastatic lung tumorsJulian Carretero, Takeshi Shimamura, Klarisa Rikova, et al.
Cancer Cell|December 16, 2022
KMT2D deficiency drives lung squamous cell carcinoma and hypersensitivity to RTK-RAS inhibitionYuanwang Pan, Han Han, Hai Hu, et al.
Cancer Immunology Research|August 31, 2021
Targeting the Atf7ip-Setdb1 Complex Augments Antitumor Immunity by Boosting Tumor ImmunogenicityHai Hu, Alireza Khodadadi-Jamayran, Igor Dolgalev, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2016
Heterogeneous Mechanisms of Primary and Acquired Resistance to Third-Generation EGFR InhibitorsSandra Ortiz-Cuaran, Matthias Scheffler, Dennis Plenker, et al.
Nature Communications|April 8, 2017
Lkb1 inactivation drives lung cancer lineage switching governed by Polycomb Repressive Complex 2Haikuo Zhang, Christine Fillmore Brainson, Shohei Koyama, et al.
Journal of Respiratory Biology and Translational Medicine|December 23, 2024
Progress and Gaps in Respiratory Disease Research and Treatment: Highlights of the IRM 2024 in ShanghaiJin-San Zhang, Qhaweni Dhlamini, Qiang Guo, et al.
Pageof 22